Literature DB >> 1577467

Cytogenetic, oncogenetic, and histopathologic characteristics of colorectal carcinomas with 17p abnormalities.

D Rau1, S Neubauer, A Köster, J Giedl, R Sachse, S Landgraf, A Leipold, T Dingermann, E Gebhart.   

Abstract

From a total of 65 colorectal adenocarcinomas studied by cytogenetic methods, 33 were selected for the present study; in addition to other karyotypic anomalies, these 33 showed a loss of the short arm of chromosome 17. This loss was either the result of a deletion or rearrangement, or caused by the loss of a whole chromosome 17. The 17p- tumors were characterized by a high grade of karyotypic abnormality including a high incidence of cases with double minutes. A gain of chromosomes 2, 7, 19, and 20, and the loss of chromosome 18 and the Y-chromosome were the most frequent numerical anomalies associated with 17p-, as were structural changes of chromosomes 1 and 5. The most impressive difference in the pattern of proto-oncogene over-expression between the 17p- tumors and those without this anomaly was the significantly increased frequency of cases with c-erbB over-expression. Some significant, but also loose, associations were found between cytogenetic/oncogenetic and histopathologic or clinical features of these tumors. The patterns of genetic changes in cells of colorectal carcinomas may thus reflect the potential of the future development, rather than the present clinical features, of the respective tumor. Therefore, the character of the change seems to be more prognostic than diagnostic.

Entities:  

Mesh:

Year:  1992        PMID: 1577467     DOI: 10.1007/bf00207044

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  13 in total

1.  Karyotype peculiarities of human colorectal adenocarcinomas.

Authors:  L N Konstantinova; E W Fleischman; V I Knisch; A G Perevozchikov; B P Kopnin
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

2.  Proto-oncogene activation in surgical specimens of rectal carcinoma.

Authors:  G Von Heimendahl; E Gebhart; T Dingermann
Journal:  Anticancer Res       Date:  1988 Jul-Aug       Impact factor: 2.480

3.  Existence of two distinct processes of chromosomal evolution in near-diploid colorectal tumors.

Authors:  M Muleris; R J Salmon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1988-05

4.  Characteristic chromosomal imbalances in 18 near-diploid colorectal tumors.

Authors:  M Muleris; R J Salmon; A M Dutrillaux; P Vielh; B Zafrani; J Girodet; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1987-12

5.  Problems of pTNM classification of carcinoma of the stomach, colorectum and anal margin.

Authors:  P Hermanek
Journal:  Pathol Res Pract       Date:  1986-06       Impact factor: 3.250

6.  Cytogenetics of colorectal adenocarcinomas.

Authors:  M Muleris; R J Salmon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1990-06

7.  Involvement of chromosomes 7 and 12 in large bowel cancer: trisomy 7 and 12q-.

Authors:  R Becher; Z Gibas; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1983-08

8.  Cytogenetic studies on human breast carcinomas.

Authors:  E Gebhart; S Brüderlein; M Augustus; E Siebert; J Feldner; W Schmidt
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  Chromosomes in human large bowel tumors. A study of chromosome #1.

Authors:  A Reichmann; P Martin; B Levin
Journal:  Cancer Genet Cytogenet       Date:  1984-08

10.  Chromosome and oncogene studies in human rectal and colon carcinomas.

Authors:  D Rau; A Köster; H Tittelbach; R Sachse; S Landgraf; S Neubauer; J Giedl; T Dingermann; E Gebhart
Journal:  Anticancer Res       Date:  1991 Jul-Aug       Impact factor: 2.480

View more
  2 in total

1.  Chromosome 1 in human colorectal tumors.

Authors:  E Gebhart; D Rau; S Neubauer; T Dingermann
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  Cytogenetic studies in lymphocytes of patients with rectal cancer.

Authors:  E Gebhart; R Romahn; A Schneider; M Hoffmann; D Rau; H Tittelbach
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.